1cs4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1cs4" size="450" color="white" frame="true" align="right" spinBox="true" caption="1cs4, resolution 2.5&Aring;" /> '''COMPLEX OF GS-ALPHA W...)
Line 1: Line 1:
-
[[Image:1cs4.gif|left|200px]]<br /><applet load="1cs4" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1cs4.gif|left|200px]]<br /><applet load="1cs4" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1cs4, resolution 2.5&Aring;" />
caption="1cs4, resolution 2.5&Aring;" />
'''COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH 2'-DEOXY-ADENOSINE 3'-MONOPHOSPHATE, PYROPHOSPHATE AND MG'''<br />
'''COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH 2'-DEOXY-ADENOSINE 3'-MONOPHOSPHATE, PYROPHOSPHATE AND MG'''<br />
==Overview==
==Overview==
-
P-site inhibitors are adenosine and adenine nucleotide analogues that, inhibit adenylyl cyclase, the effector enzyme that catalyzes the synthesis, of cyclic AMP from ATP. Some of these inhibitors may represent, physiological regulators of adenylyl cyclase, and the most potent may, ultimately serve as useful therapeutic agents. Described here are crystal, structures of the catalytic core of adenylyl cyclase complexed with two, such P-site inhibitors, 2'-deoxyadenosine 3'-monophosphate (2'-d-3'-AMP), and 2',5'-dideoxyadenosine 3'-triphosphate (2',5'-dd-3'-ATP). Both, inhibitors bind in the active site yet exhibit non- or uncompetitive, patterns of inhibition. While most P-site inhibitors require pyrophosphate, (PP(i)) as a coinhibitor, 2',5'-dd-3'-ATP is a potent inhibitor by itself., The crystal structure reveals that this inhibitor exhibits two binding, modes: one with the nucleoside moiety bound to the nucleoside binding, pocket of the enzyme and the other with the beta and gamma phosphates, bound to the pyrophosphate site of the 2'-d-3'-AMP.PP(i) complex. A single, metal binding site is observed in the complex with 2'-d-3'-AMP, whereas, two are observed in the complex with 2', 5'-dd-3'-ATP. Even though P-site, inhibitors are typically 10 times more potent in the presence of Mn(2+), the electron density maps reveal no inherent preference of either metal, site for Mn(2+) over Mg(2+). 2',5'-dd-3'-ATP binds to the catalytic core, of adenylyl cyclase with a K(d) of 2.4 microM in the presence of Mg(2+), and 0.2 microM in the presence of Mn(2+). Pyrophosphate does not compete, with 2',5'-dd-3'-ATP and enhances inhibition.
+
P-site inhibitors are adenosine and adenine nucleotide analogues that inhibit adenylyl cyclase, the effector enzyme that catalyzes the synthesis of cyclic AMP from ATP. Some of these inhibitors may represent physiological regulators of adenylyl cyclase, and the most potent may ultimately serve as useful therapeutic agents. Described here are crystal structures of the catalytic core of adenylyl cyclase complexed with two such P-site inhibitors, 2'-deoxyadenosine 3'-monophosphate (2'-d-3'-AMP) and 2',5'-dideoxyadenosine 3'-triphosphate (2',5'-dd-3'-ATP). Both inhibitors bind in the active site yet exhibit non- or uncompetitive patterns of inhibition. While most P-site inhibitors require pyrophosphate (PP(i)) as a coinhibitor, 2',5'-dd-3'-ATP is a potent inhibitor by itself. The crystal structure reveals that this inhibitor exhibits two binding modes: one with the nucleoside moiety bound to the nucleoside binding pocket of the enzyme and the other with the beta and gamma phosphates bound to the pyrophosphate site of the 2'-d-3'-AMP.PP(i) complex. A single metal binding site is observed in the complex with 2'-d-3'-AMP, whereas two are observed in the complex with 2', 5'-dd-3'-ATP. Even though P-site inhibitors are typically 10 times more potent in the presence of Mn(2+), the electron density maps reveal no inherent preference of either metal site for Mn(2+) over Mg(2+). 2',5'-dd-3'-ATP binds to the catalytic core of adenylyl cyclase with a K(d) of 2.4 microM in the presence of Mg(2+) and 0.2 microM in the presence of Mn(2+). Pyrophosphate does not compete with 2',5'-dd-3'-ATP and enhances inhibition.
==About this Structure==
==About this Structure==
-
1CS4 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus], [http://en.wikipedia.org/wiki/Canis_lupus_familiaris Canis lupus familiaris] and [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with MG, CL, GSP, 101, FOK, MES and POP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Adenylate_cyclase Adenylate cyclase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.6.1.1 4.6.1.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1CS4 OCA].
+
1CS4 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus], [http://en.wikipedia.org/wiki/Canis_lupus_familiaris Canis lupus familiaris] and [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=CL:'>CL</scene>, <scene name='pdbligand=GSP:'>GSP</scene>, <scene name='pdbligand=101:'>101</scene>, <scene name='pdbligand=FOK:'>FOK</scene>, <scene name='pdbligand=MES:'>MES</scene> and <scene name='pdbligand=POP:'>POP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Adenylate_cyclase Adenylate cyclase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.6.1.1 4.6.1.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1CS4 OCA].
==Reference==
==Reference==
Line 16: Line 16:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Rattus norvegicus]]
[[Category: Rattus norvegicus]]
-
[[Category: Dessauer, C.A.]]
+
[[Category: Dessauer, C A.]]
-
[[Category: Gilman, A.G.]]
+
[[Category: Gilman, A G.]]
-
[[Category: Johnson, R.A.]]
+
[[Category: Johnson, R A.]]
-
[[Category: Sprang, S.R.]]
+
[[Category: Sprang, S R.]]
-
[[Category: Sunahara, R.K.]]
+
[[Category: Sunahara, R K.]]
-
[[Category: Tesmer, J.J.G.]]
+
[[Category: Tesmer, J J.G.]]
[[Category: 101]]
[[Category: 101]]
[[Category: CL]]
[[Category: CL]]
Line 36: Line 36:
[[Category: signal transducing protein]]
[[Category: signal transducing protein]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 12:43:05 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:09:16 2008''

Revision as of 10:09, 21 February 2008


1cs4, resolution 2.5Å

Drag the structure with the mouse to rotate

COMPLEX OF GS-ALPHA WITH THE CATALYTIC DOMAINS OF MAMMALIAN ADENYLYL CYCLASE: COMPLEX WITH 2'-DEOXY-ADENOSINE 3'-MONOPHOSPHATE, PYROPHOSPHATE AND MG

Overview

P-site inhibitors are adenosine and adenine nucleotide analogues that inhibit adenylyl cyclase, the effector enzyme that catalyzes the synthesis of cyclic AMP from ATP. Some of these inhibitors may represent physiological regulators of adenylyl cyclase, and the most potent may ultimately serve as useful therapeutic agents. Described here are crystal structures of the catalytic core of adenylyl cyclase complexed with two such P-site inhibitors, 2'-deoxyadenosine 3'-monophosphate (2'-d-3'-AMP) and 2',5'-dideoxyadenosine 3'-triphosphate (2',5'-dd-3'-ATP). Both inhibitors bind in the active site yet exhibit non- or uncompetitive patterns of inhibition. While most P-site inhibitors require pyrophosphate (PP(i)) as a coinhibitor, 2',5'-dd-3'-ATP is a potent inhibitor by itself. The crystal structure reveals that this inhibitor exhibits two binding modes: one with the nucleoside moiety bound to the nucleoside binding pocket of the enzyme and the other with the beta and gamma phosphates bound to the pyrophosphate site of the 2'-d-3'-AMP.PP(i) complex. A single metal binding site is observed in the complex with 2'-d-3'-AMP, whereas two are observed in the complex with 2', 5'-dd-3'-ATP. Even though P-site inhibitors are typically 10 times more potent in the presence of Mn(2+), the electron density maps reveal no inherent preference of either metal site for Mn(2+) over Mg(2+). 2',5'-dd-3'-ATP binds to the catalytic core of adenylyl cyclase with a K(d) of 2.4 microM in the presence of Mg(2+) and 0.2 microM in the presence of Mn(2+). Pyrophosphate does not compete with 2',5'-dd-3'-ATP and enhances inhibition.

About this Structure

1CS4 is a Protein complex structure of sequences from Bos taurus, Canis lupus familiaris and Rattus norvegicus with , , , , , and as ligands. Active as Adenylate cyclase, with EC number 4.6.1.1 Full crystallographic information is available from OCA.

Reference

Molecular basis for P-site inhibition of adenylyl cyclase., Tesmer JJ, Dessauer CW, Sunahara RK, Murray LD, Johnson RA, Gilman AG, Sprang SR, Biochemistry. 2000 Nov 28;39(47):14464-71. PMID:11087399

Page seeded by OCA on Thu Feb 21 12:09:16 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools